WallStSmart

Banzai International Inc (BNZI)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 2029% more annual revenue ($258.90M vs $12.16M). ZEPP leads profitability with a -15.5% profit margin vs -184.9%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

BNZI

Hold

41

out of 100

Grade: D

Growth: 5.3Profit: 2.0Value: 6.7Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BNZIUndervalued (+55.5%)

Margin of Safety

+55.5%

Fair Value

$2.83

Current Price

$0.30

$2.53 discount

UndervaluedFair: $2.83Overvalued
ZEPPUndervalued (+48.8%)

Margin of Safety

+48.8%

Fair Value

$46.82

Current Price

$17.47

$29.35 discount

UndervaluedFair: $46.82Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BNZI2 strengths · Avg: 10.0/10
Price/BookValuation
0.4x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
116.3%10/10

Revenue surging 116.3% year-over-year

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

BNZI4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$6.67M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-850.0%2/10

ROE of -850.0% — below average capital efficiency

Free Cash FlowQuality
$-2.29M2/10

Negative free cash flow — burning cash

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : BNZI

The strongest argument for BNZI centers on Price/Book, Revenue Growth. Revenue growth of 116.3% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : BNZI

The primary concerns for BNZI are EPS Growth, Market Cap, Return on Equity.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

BNZI is growing revenue faster at 116.3% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

BNZI scores higher overall (41/100 vs 41/100) and 116.3% revenue growth. ZEPP offers better value entry with a 48.8% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Banzai International Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Banzai International Inc (BNZI) is an innovative technology and digital media company that focuses on interactive entertainment and consumer engagement solutions. Leveraging cutting-edge technologies, the firm offers a wide array of products designed to enhance user experiences and optimize business strategies for a broad spectrum of clients. With its strategic positioning in the fast-growing digital content and immersive technology markets, Banzai International represents a compelling investment opportunity for institutional investors seeking to capitalize on the evolution of the technology sector.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?